2-218781813-T-C
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The ENST00000494263.5(CYP27A1):n.65T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000366 in 92,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0083 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000089 ( 0 hom. )
Consequence
CYP27A1
ENST00000494263.5 non_coding_transcript_exon
ENST00000494263.5 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.910
Publications
1 publications found
Genes affected
CYP27A1 (HGNC:2605): (cytochrome P450 family 27 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This mitochondrial protein oxidizes cholesterol intermediates as part of the bile synthesis pathway. Since the conversion of cholesterol to bile acids is the major route for removing cholesterol from the body, this protein is important for overall cholesterol homeostasis. Mutations in this gene cause cerebrotendinous xanthomatosis, a rare autosomal recessive lipid storage disease. [provided by RefSeq, Jul 2008]
CYP27A1 Gene-Disease associations (from GenCC):
- cerebrotendinous xanthomatosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Genomics England PanelApp, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00826 (26/3148) while in subpopulation AMR AF = 0.0324 (9/278). AF 95% confidence interval is 0.0169. There are 0 homozygotes in GnomAd4. There are 12 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP27A1 | ENST00000494263.5 | n.65T>C | non_coding_transcript_exon_variant | Exon 1 of 7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00826 AC: 26AN: 3146Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
26
AN:
3146
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000892 AC: 8AN: 89652Hom.: 0 Cov.: 0 AF XY: 0.000154 AC XY: 7AN XY: 45464 show subpopulations
GnomAD4 exome
AF:
AC:
8
AN:
89652
Hom.:
Cov.:
0
AF XY:
AC XY:
7
AN XY:
45464
show subpopulations
African (AFR)
AF:
AC:
0
AN:
2298
American (AMR)
AF:
AC:
0
AN:
2410
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2942
East Asian (EAS)
AF:
AC:
0
AN:
4980
South Asian (SAS)
AF:
AC:
0
AN:
6856
European-Finnish (FIN)
AF:
AC:
0
AN:
5906
Middle Eastern (MID)
AF:
AC:
0
AN:
456
European-Non Finnish (NFE)
AF:
AC:
5
AN:
58024
Other (OTH)
AF:
AC:
3
AN:
5780
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00826 AC: 26AN: 3148Hom.: 0 Cov.: 31 AF XY: 0.00786 AC XY: 12AN XY: 1526 show subpopulations
GnomAD4 genome
AF:
AC:
26
AN:
3148
Hom.:
Cov.:
31
AF XY:
AC XY:
12
AN XY:
1526
show subpopulations
African (AFR)
AF:
AC:
2
AN:
654
American (AMR)
AF:
AC:
9
AN:
278
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
106
East Asian (EAS)
AF:
AC:
0
AN:
96
South Asian (SAS)
AF:
AC:
0
AN:
44
European-Finnish (FIN)
AF:
AC:
0
AN:
158
Middle Eastern (MID)
AF:
AC:
0
AN:
4
European-Non Finnish (NFE)
AF:
AC:
14
AN:
1760
Other (OTH)
AF:
AC:
1
AN:
32
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Cholestanol storage disease Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.